Annual report
2914.TEDINET S100T3QS
Period2023-01-01 → 2023-12-31
Filed2024-03-22
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.84T | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥2.66T | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥2.32T | 2021-01-01 → 2021-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.09T | 2020-01-01 → 2020-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.18T | 2019-01-01 → 2019-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥672.4bn | 2023-01-01 → 2023-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥653.6bn | 2022-01-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥621.6bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥593.5bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥472.4bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥420.1bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥465.2bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥482.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥442.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥338.5bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥310.3bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥348.2bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥485.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥444.2bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥340.2bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥312.0bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥361.6bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥7.28T | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥6.55T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥5.77T | at 2021-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥5.38T | at 2020-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥5.55T | at 2019-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.37T | at 2023-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥2.93T | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥3.91T | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.62T | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.89T | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥3.83T | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥3.54T | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥1.04T | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥866.9bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥721.7bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥538.8bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥357.2bn | at 2019-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥567.0bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥483.8bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥598.9bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥519.8bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥540.4bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥126.1bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥101.8bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥97.5bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥5.4bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥123.6bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥270.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥306.2bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥353.1bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥297.4bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥333.8bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥271.69 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥249.45 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥190.76 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥174.88 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥195.97 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥271.63 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥249.36 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥190.68 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥174.8 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥195.87 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥2,157.46 | at 2023-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,994.78 | at 2022-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,583.1 | at 2021-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,421.92 | at 2020-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,501.12 | at 2019-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 52.6% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 54.1% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.6% | at 2021-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 46.9% | at 2020-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 47.9% | at 2019-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 13.1% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 13.9% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 12.7% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 12.0% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 13.2% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 53,239 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 52,640 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 55,381 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 58,300 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 61,975 | at 2019-12-31d | Cons. | Number of employees |
| Revenue | ¥537.3bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥542.2bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥592.2bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥596.9bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥660.8bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥20.1bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | ¥64.6bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | ¥185.7bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥273.7bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥278.8bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥240.5bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥279.0bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥195.1bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥310.1bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | ¥184.8bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥283.5bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥216.9bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥241.8bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥262.5bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.29T | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥2.36T | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥2.49T | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.60T | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.61T | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.11T | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥994.6bn | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.18T | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.37T | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.34T | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥1.39T | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.42T | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥177.7bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥193.4bn | at 2022-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥104.1 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥159.72 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥122.23 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥136.27 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥147.72 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥104.07 | 2023-01-01 → 2023-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥159.66 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥122.18 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥136.21 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥147.65 | 2019-01-01 → 2019-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥194 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥188 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥140 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥154 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥154 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥664.12 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥770.57 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥757.1 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥782.73 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥798.18 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 51.4% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.9% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.0% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.5% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.2% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 14.5% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 20.9% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.9% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.2% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.1% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,000,000,000 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,000,000,000 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,000,000,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,000,000,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,000,000,000 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 5,940 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 5,819 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 7,154 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 7,366 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 7,464 | at 2019-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 85
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-01-01 → 2023-12-31 | ¥7.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-12-31 | ¥4.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-12-31 | ¥1.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥2.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-12-31 | −¥46.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-12-31 | −¥46.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-12-31 | −¥29.9bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-12-31 | −¥3.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-12-31 | −¥3.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | ¥124m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | ¥124m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | ¥124m |
| Pharmaceuticalsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥7.3bn |
| Pharmaceuticalsreportable segment | employees | at 2023-12-31 | 1338 pure |
| Pharmaceuticalsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥94.9bn |
| Pharmaceuticalsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥94.9bn |
| Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥17.4bn |
| Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥17.4bn |
| Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥17.4bn |
| Processed Foodreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥5.8bn |
| Processed Foodreportable segment | employees | at 2023-12-31 | 4299 pure |
| Processed Foodreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥153.9bn |
| Processed Foodreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥153.9bn |
| Processed Foodreportable segment | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥31m |
| Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥6.8bn |
| Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥6.8bn |
| Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥7.7bn |
| Tobaccoreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥105.1bn |
| Tobaccoreportable segment | employees | at 2023-12-31 | 46698 pure |
| Tobaccoreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥2.59T |
| Tobaccoreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥2.59T |
| Tobaccoreportable segment | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥393m |
| Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥749.8bn |
| Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥749.8bn |
| Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥677.1bn |
| —segment total | capex | 2023-01-01 → 2023-12-31 | ¥118.3bn |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥2.84T |
| —segment total | revenue external | 2023-01-01 → 2023-12-31 | ¥2.84T |
| —segment total | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥425m |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥774.0bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥774.0bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥702.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-01-01 → 2022-12-31 | ¥6.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-12-31 | ¥9.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-12-31 | ¥2.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥7.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-12-31 | −¥40.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-12-31 | −¥40.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-12-31 | −¥41.1bn |
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥0 |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-12-31 | −¥7.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-12-31 | −¥7.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥52m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥52m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥52m |
| Pharmaceuticalsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥2.4bn |
| Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥82.9bn |
| Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥82.9bn |
| Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥11.1bn |
| Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥11.1bn |
| Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥11.1bn |
| Processed Foodreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥8.2bn |
| Processed Foodreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥155.5bn |
| Processed Foodreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥155.5bn |
| Processed Foodreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥3m |
| Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥3.5bn |
| Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥3.5bn |
| Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥4.2bn |
| Tobaccoreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥83.8bn |
| Tobaccoreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥2.42T |
| Tobaccoreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥2.42T |
| Tobaccoreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥332m |
| Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥754.0bn |
| Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥754.0bn |
| Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥679.4bn |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥94.4bn |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥2.66T |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥2.66T |
| —segment total | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥335m |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥768.7bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥768.7bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥694.7bn |
| Pharmaceuticalsreportable segment | employees | at 2023-12-31 | 715 pure |
| Processed Foodreportable segment | employees | at 2023-12-31 | 24 pure |
| Tobaccoreportable segment | employees | at 2023-12-31 | 4781 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,189
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of issues whose number of shares increased shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Total acquisition cost for increased shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | JPY |
| Number of issues whose number of shares decreased shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | 9 | |
| Total sale amount for decreased shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | 89000000 | JPY |
| Number of issues whose number of shares decreased shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | 3 | |
| Total sale amount for decreased shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | 688000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | 852000 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row1Member | 852000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | 4767000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row1Member | 4822000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | 1320000 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row2Member | 1320000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | 2876000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row2Member | 2269000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | 400000 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row3Member | 400000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | 2484000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row3Member | 2612000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | － | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row4Member | 100000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | － | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row4Member | 1621000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | 552500 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row5Member | 1052500 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | 576000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row5Member | 682000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | 173040 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row6Member | 173040 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | 1387000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row6Member | 1305000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | 602000 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row7Member | 602000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | 822000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row7Member | 575000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | － | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row8Member | 27400 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | － | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row8Member | 48000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 866885000000 | JPY |
| Cash and cash equivalents IFRS | CurrentYearInstant | 1040206000000 | JPY |
| Trade and other receivables ca IFRS | Prior1YearInstant | 477239000000 | JPY |
| Trade and other receivables ca IFRS | CurrentYearInstant | 535302000000 | JPY |
| Inventories ca IFRS | Prior1YearInstant | 691906000000 | JPY |
| Inventories ca IFRS | CurrentYearInstant | 832611000000 | JPY |
| Other financial assets ca IFRS | Prior1YearInstant | 37677000000 | JPY |
| Other financial assets ca IFRS | CurrentYearInstant | 58633000000 | JPY |
| Other current assets ca IFRS | Prior1YearInstant | 649181000000 | JPY |
| Other current assets ca IFRS | CurrentYearInstant | 789888000000 | JPY |
| Current assets other than assets held for sale ca IFRS | Prior1YearInstant | 2722889000000 | JPY |
| Current assets other than assets held for sale ca IFRS | CurrentYearInstant | 3256639000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |